Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | HRH1 | P35367 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.49 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.47 |
| ▸ | TBXAS1 | P24557 | 3/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5724954 | 0.89 | CYP2A6 (0.59) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 | |
| SCHEMBL10772071 | 0.85 | HRH1 (0.62) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 | |
| SCHEMBL10768402 | 0.85 | HRH1 (0.62) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 | |
| Pivalate SCHEMBL28287323 | 0.84 | TBXAS1 (0.49) | CHRNA7TDP1L3MBTL1CYP1A2TBXAS1 | |
| SCHEMBL8710717 | 0.82 | CHRNA7 (0.59) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 | |
| SCHEMBL8710719 | 0.82 | CHRNA7 (0.59) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 | |
| SCHEMBL724866 | 0.80 | CHRNA7 (0.74) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 | |
| SCHEMBL29485692 | 0.80 | CHRNA7 (0.74) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 | |
| SCHEMBL348855 | 0.80 | CHRNA7 (0.57) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 | |
| SCHEMBL7052160 | 0.80 | CHRNA7 (0.57) | CHRNA7CYP2A6TDP1L3MBTL1HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724034-A1 | SYNERGISTIC ANTIOXIDANT COMPOSITIONS | The Procter & Gamble Company (US) | 2026-04-15 | — | — | EP | disclosed |
| EP-4628066-A2 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | The Procter & Gamble Company (US) | 2025-10-08 | — | — | EP | disclosed |
| EP-3768389-B1 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS | PROCTER & GAMBLE (US) | 2025-09-03 | — | — | EP | disclosed |
| US-20250099358-A1 | SHAVING AID COMPRISING A BENEFIT AGENT | GILLETTE CO LLC (US) | 2025-03-27 | — | — | US | disclosed |
| US-12194126-B2 | Shaving aid comprising a benefit agent | THE GILLETTE COMPANY LLC (US) | 2025-01-14 | — | — | US | disclosed |
| US-20240407990-A1 | SYNERGISTIC ANTIOXIDANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY | 2024-12-12 | — | — | US | disclosed |
| WO-2024254280-A1 | SYNERGISTIC ANTIOXIDANT COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2024-12-12 | — | — | WO | disclosed |
| US-20240315944-A1 | DEODORANT AND ANTIPERSPIRANT COMPOSITIONS | PROCTER & GAMBLE (US) | 2024-09-26 | — | — | US | disclosed |
| US-12036301-B2 | Deodorant and antiperspirant compositions | THE PROCTER & GAMBLE COMPANY (US) | 2024-07-16 | — | — | US | disclosed |
| CN-113873989-B | Synergistic anti-inflammatory compositions | 宝洁公司 | 2024-05-28 | — | — | CN | disclosed |
| EP-0500653-A4 | INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE | BIOCRYST INC (US) | 1995-08-23 | — | — | EP | disclosed |
| CN-1084173-A | 1-azabicyclo [3,2,0] hept-2-ene\"-2-carboxylic acid derivative and preparation thereof | FUJISAWA PHARMACEUTICAL CO (JP) | 1994-03-23 | — | — | CN | disclosed |
| US-5286721-A | Antimicrobial agents | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-02-15 | — | — | US | disclosed |
| WO-1993023402-A1 | 3-AZETIDINYLTHIO-CARBAPENEME DERIVATIVES, THEIR PREPARATION AND USE AS ANTIMICROBIAL AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-11-25 | — | — | WO | disclosed |
| EP-0500653-A1 | INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE | BIOCRYST PHARMACEUTICALS INC. (US) | 1992-09-02 | — | — | EP | disclosed |
| WO-1992006978-A1 | 1-AZABICYCLO[3.2.0]HEPT-2-ENE-2-CARBOXYLIC ACID COMPOUNDS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1992-04-30 | — | — | WO | disclosed |
| WO-1991006548-A1 | INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE | BIOCRYST, INC. (US) | 1991-05-16 | — | — | WO | disclosed |
| US-5008270-A | 2-amino-7-(heterocyclomethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same | BIOCRYST, INC. (US) | 1991-04-16 | — | — | US | disclosed |
| US-4985433-A | 2-amino-7-(pyridinylmethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same | BIOCRYST, INC. (US) | 1991-01-15 | — | — | US | disclosed |
| EP-0372470-A2 | Novel alpha-cyano-beta-oxopropionamides | CIBA-GEIGY AG (CH) | 1990-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12036301-B2 | Deodorant and antiperspirant compositions | LPO, TH, PON1 | CHRNA7 3616/4885MEN1 4104/4885KMT2A 2748/4885 |
| US-20240315944-A1 | DEODORANT AND ANTIPERSPIRANT COMPOSITIONS | NAPRT, QDPR, NAMPT | CHRNA7 587/4885MEN1 1007/4885KMT2A 2356/4885 |
| US-20240407990-A1 | SYNERGISTIC ANTIOXIDANT COMPOSITIONS | NQO1, PNPO, PROC | CHRNA7 2079/4885MEN1 3017/4885KMT2A 4179/4885 |
| US-12194126-B2 | Shaving aid comprising a benefit agent | CUTA, CDC73, ASPH | CHRNA7 4450/4885MEN1 1853/4885KMT2A 473/4885 |
| US-20250099358-A1 | SHAVING AID COMPRISING A BENEFIT AGENT | CUTA, CDC73, ASPH | CHRNA7 4450/4885MEN1 1853/4885KMT2A 473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.